BIOMARKER:

HER-2 exon 20 insertion

Entrez ID:

Related biomarkers:

‹

›

HER-2 exon 20 insertion HER-2 exon 20 insertion	Solid Tumor Solid Tumor	BDTX-189 Sensitive: B - Late Trials
HER-2 exon 20 insertion HER-2 exon 20 insertion	Lung Adenocarcinoma LUAD	ado-trastuzumab emtansine Sensitive: C3 – Early Trials
HER-2 exon 20 insertion HER-2 exon 20 insertion	Non Small Cell Lung Cancer NSCLC	dacomitinib Sensitive: C3 – Early Trials
HER-2 exon 20 insertion HER-2 exon 20 insertion	Non Small Cell Lung Cancer NSCLC	rivoceranib + pyrotinib Sensitive: C3 – Early Trials
HER-2 exon 20 insertion HER-2 exon 20 insertion	Lung Adenocarcinoma LUAD	afatinib Sensitive: C4 – Case Studies
HER-2 exon 20 insertion HER-2 exon 20 insertion	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	neratinib + ado-trastuzumab emtansine Sensitive: D – Preclinical
HER-2 exon 20 insertion HER-2 exon 20 insertion	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	neratinib + fam-trastuzumab deruxtecan-nxki Sensitive: D – Preclinical
HER-2 exon 20 insertion HER-2 exon 20 insertion	Lung Adenocarcinoma LUAD	HM 78136B Sensitive: D – Preclinical